RNA interference: implications for cancer treatment

scientific article published on 11 January 2007

RNA interference: implications for cancer treatment is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.MAM.2006.12.004
P698PubMed publication ID17307250
P5875ResearchGate publication ID6498818

P50authorStefano IndraccoloQ39186456
Elena FavaroQ58314073
P2093author name stringGiorgia Nardo
Massimo Masiero
P2860cites workMutations of the BRAF gene in human cancerQ27860760
Cellular and gene expression responses involved in the rapid growth inhibition of human cancer cells by RNA interference-mediated depletion of telomerase RNA.Q40435095
RNA interference targeting the M2 subunit of ribonucleotide reductase enhances pancreatic adenocarcinoma chemosensitivity to gemcitabineQ40609648
Telomere states and cell fatesQ46830116
P433issue1
P921main subjectRNA interferenceQ201993
P304page(s)143-166
P577publication date2007-01-11
P13046publication type of scholarly workreview articleQ7318358
P1433published inMolecular Aspects of MedicineQ6895933
P1476titleRNA interference: implications for cancer treatment
P478volume28

Reverse relations

cites work (P2860)
Q43846123Adenoviral delivered eGFP-intron splicing system for multiple gene RNAi
Q37857396Can non-viral technologies knockdown the barriers to siRNA delivery and achieve the next generation of cancer therapeutics?
Q39018787Cancer-targeting siRNA delivery from porous silicon nanoparticles
Q51001472Downregulation of ABCE1 via siRNA affects the sensitivity of A549 cells against chemotherapeutic agents
Q39814192Downregulation of IGF-IR expression by RNAi inhibits proliferation and enhances chemosensitization of human colon cancer cells
Q38204377Epigenetic biomarkers: potential applications in gastrointestinal cancers
Q39989246Establishment of CXCR4-small interfering RNA retrovirus vector driven by human prostate-specific antigen promoter and its biological effects on prostate cancer in vitro and in vivo
Q38396813Expression of Opa interacting protein 5 (OIP5) is associated with tumor stage and prognosis of clear cell renal cell carcinoma
Q39632452In Vitro and In Vivo Inhibition of MRP Gene Expression and Reversal of Multidrug Resistance by siRNA
Q27486413Inhibition of alphavirus infection in cell culture and in mice with antisense morpholino oligomers
Q34456173Inhibition of hepatitis B virus and induction of hepatoma cell apoptosis by ASGPR-directed delivery of shRNAs
Q39643674Inhibitory Effect of Small Interfering RNA Targeting Insulin-Like Growth Factor-I Receptor in Ovarian Cancer OVCAR3 Cells
Q42324117Intracellular Delivery of siRNA by Polycationic Superparamagnetic Nanoparticles
Q33777055Is there a role for voltage-gated Na+ channels in the aggressiveness of breast cancer?
Q37039021Liposomal nanomedicines
Q46705002Liposomal nanomedicines: an emerging field
Q38151549Nanooncology: the future of cancer diagnosis and therapy
Q38037048Nanoparticle-based delivery of small interfering RNA: challenges for cancer therapy
Q38743723RNAi Screening of the Glucose-Regulated Chaperones in Cancer with Self-Assembled siRNA Nanostructures
Q35750000RNAi Targeting CXCR4 Inhibits Tumor Growth Through Inducing Cell Cycle Arrest and Apoptosis
Q39735343Small interference RNA targeting Krüppel-like factor 8 inhibits the renal carcinoma 786-0 cells growth in vitro and in vivo
Q58909203Superparamagnetic Nanoparticles and RNAi-Mediated Gene Silencing: Evolving Class of Cancer Diagnostics and Therapeutics
Q33713264Targeting hypoxia-inducible factor-1alpha with Tf-PEI-shRNA complex via transferrin receptor-mediated endocytosis inhibits melanoma growth

Search more.